Tag Archives | immuno-oncology

Sideways Market Vexes Traders: Biotech Stocks are Fading…Updates-3 Rally Time!

Update-3…3/11…Gene Therapy stocks go green screen! Big 5% winners: VYGR NTLA BLUE EDIT See complete list below (paste list into yahoo finance for tracking) Update-2…3/11…Market gets support from 60 Minutes-Powell comments and Gene Therapy; NASDAQ up 1.77%; XBI up 1.74% to $87.94  as of 1:15p Update-1… 3/10…Friday’s Comeback needs some follow through with small caps: […]

Continue Reading 0

Small Cap Biotechs Lead the Market in 2019 Up 20% YTD…GNMK, ONCE, XBI-Updates

Update: 1:40 EST 2/25… Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%. Another big deal as GE sells healthcare business to Danher (DHR) for $21.4B; GE up 8.26%, DHR up 8.38%. ========== M&A Drives Mid and Small Cap Biotechs Stocks Higher The Small Cap weighted XBI is up […]

Continue Reading 0

Biotech Stocks Hold After After Brief Sell-Off Last Week…Updates

Biotech Stocks Hold Despite Last Thursday’s Sell-Off All in the Technicals For Now, Large Caps Look Steady Biotech ETFs lost momentum last week but held near term support near the 20 Day moving average. Now that most  companies have reported we should not expect fundamentals to create volatility. Rather we may be stuck in a […]

Continue Reading 0

Life Science ETFs Performance 2018-2019: FBT is the Leader…Updates 2/7

Update 2/7/19 Mid-Day Trading : Risk Off Day The market is trending down with all major indices in the red and the XBI $81.96 down 2.75%. We sold our position in the XBI yesterday at $83+. Array (ARRY) continues to run up at $21.60. Hot stock MacroGenics (MGNX) cooled off down 9% to $23.29. Issues […]

Continue Reading 0

What’s Up with the Biotech Rally?…Updates

Update-2 1/21/19…Heads Up Red Futures Growth worries return-Asian Stocks down IMF Lowers Global Growth-Poor Performance for Europe Biotech rally could stall Update-1 1/20/19…XBI at $83.38 approaching November resistance at $85 Barron’s 2019 Roundtable biopharma picks: Abbvie (ABBV), Roche Holding (ROG), Gilead Sciences (GILD). ======= Biotech Rally Continues from the J.P.Morgan Healthcare Conference Slow and steady […]

Continue Reading 0

Big Biopharma Bounce off Bottom: Mid Caps…Updates

1/7/19 …After Close: Most Mid-Caps held gains but check AH trading Selected Winners today: AGIO 8.7%, ALNY 8.75%, ARRY 8.85%, BLUE 6.67%, BPMC 14.1%, NKTR 7.83%, SGEN 5.68%, ICPT 7.28%, XBI 5.97% (closed at highs. $79.50). Many of these mid-caps are still at low end of 52 week range. Selected stocks above 52 week mid-range: […]

Continue Reading 0

Large Cap Biopharmaceutical Performance 2018…Updates BMY CELG, XBI

1/7/19 After Close: Both BMY and CELG held today up over 3%. ==== Stay tuned Next Week for Updates from the J.P.Morgan Healthcare Conference 1/5/19 Friday’s broad-based biopharmaceutical rally boosts stocks out of a “Bear Market”which brought the XBI down 25% off highs to the  $64 level on December 24, 2018 and now at $75. […]

Continue Reading 0

Free Falling Biotech Stocks Hit New 52 Week Lows…Updates 12/29

Update: 12/29/18 Biotech Stocks Halt Slide: IBB down 0.34% to $94.84 and up 4.7% for the week, XBI up 0.73% to $70.09 and up 5.6% for the week. XLV up 3.5% for the week to $85.25.Volatile market trying to hold DEC 24 bottom. Recent trades that worked: ABBV AMGN ; did not work ALXN CELG […]

Continue Reading 0

Bull Case for Biotech Remains Elusive-Trade Carefully…Update after FED Meeting

Update-2 After close: Market Collapses After FED Meeting-Bear Market  WE all knew that the biotech sector likes looser monetary policy but this sell-off is ridiculous. The IBB is now at May 2017 levels! XBI breaks through 2018 technicals down 3.33% on downside to $71.20, now at June 2017 lows. Update-1 1 pm 12/19/18 Green Day […]

Continue Reading 0

Trade Fears Derail Biotech Rally in a Jittery Market…Updates

Update -4 After Close 12/7/18 Market Performance for the Week XBI down 7.8%, IBB down 6.6%, XLV down 5.2%, QQQ down 5.11%. Futures not looking good at 12:40a EST, NAZ down 0.82%. Global Growth worries mount; geopolitical turmoil reigns. Moderna (MRNA) IPO closes down 19.13% to $18.60: Largest Biotech to Go Public…https://finance.yahoo.com/news/nasdaq-welcomes-moderna-inc-nasdaq-185435974.html ======= Update-3 After […]

Continue Reading 0